Cargando…
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells
Chemotherapy is the standard of care for most malignancies. Its tumor debulking effect in adjuvant or neoadjuvant settings is unquestionable, although secondary effects have been reported that paradoxically promote metastasis. Chemotherapy affects the hematopoietic precursors leading to myelosuppres...
Autores principales: | Russo, Massimo, Panini, Nicolò, Fabbrizio, Paola, Formenti, Laura, Becchetti, Riccardo, Matteo, Cristina, Meroni, Marina, Nastasi, Claudia, Cappelleri, Andrea, Frapolli, Roberta, Nardo, Giovanni, Scanziani, Eugenio, Ponzetta, Andrea, Bani, Maria Rosa, Ghilardi, Carmen, Giavazzi, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395252/ https://www.ncbi.nlm.nih.gov/pubmed/37538353 http://dx.doi.org/10.1080/2162402X.2023.2239035 |
Ejemplares similares
-
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor’s proangiogenic microenvironment
por: Silini, Antonietta, et al.
Publicado: (2011) -
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer
por: Ghilardi, Carmen, et al.
Publicado: (2022) -
Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium
por: Ghilardi, Carmen, et al.
Publicado: (2008) -
Pseudo-resistance to anticancer drugs
por: Davoli, Enrico, et al.
Publicado: (2022) -
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin
por: Dellavedova, Giulia, et al.
Publicado: (2023)